ClinConnect ClinConnect Logo
Search / Trial NCT07065721

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

Launched by SAN DIEGO STATE UNIVERSITY · Jul 9, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Continuous Glucose Monitor Type 2 Diabetes Young Adult

ClinConnect Summary

This study is looking at how young adults with type 2 diabetes can use a device called a continuous glucose monitor (CGM) to better manage their blood sugar levels. The CGM is a small sensor that tracks glucose (sugar) in the body throughout the day and night, giving users real-time information about their blood sugar patterns. The study will provide these devices to participants for 30 days to see how easy they are to use, what helps or makes it harder for people to use them, and how using the CGM might change their awareness of their blood sugar levels.

To take part, people need to be between 18 and 45 years old, have been diagnosed with type 2 diabetes within the last five years, and have never used a CGM before. Participants also need a smartphone that works with the Dexcom CGM app and be comfortable using it in English or Spanish. People who are pregnant, recently had a baby, or have serious mental health conditions won’t be able to join. During the study, participants will wear the CGM for a month and share their experiences to help researchers understand how this technology might support better diabetes self-care in young adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult 18-45 years of age
  • diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record
  • no prior use or experience with wearable CGMs
  • possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app
  • fluency in English or Spanish
  • Exclusion Criteria:
  • severe mental illness (e.g., psychosis, suicidal ideation);
  • pregnancy or \<6 months postpartum

About San Diego State University

San Diego State University (SDSU) is a leading academic institution recognized for its commitment to research and innovation in various fields, including health sciences. With a robust infrastructure for clinical trials, SDSU engages in cutting-edge research aimed at advancing medical knowledge and improving patient care. The university fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, enabling the development of novel therapeutic interventions and evidence-based practices. SDSU's dedication to ethical standards and rigorous scientific methodologies ensures that its clinical trials contribute valuable insights to the medical community and enhance public health outcomes.

Locations

San Diego, California, United States

Patients applied

0 patients applied

Trial Officials

Jessica L McCurley, PhD MPH

Principal Investigator

San Diego State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported